Drug's success suggests new protocols for stroke treatment

Article Abstract:

The emergence of tissue plasminogen activator (t-PA) changes the way that physicians and hospitals must deal with stroke victims. A study conducted by the National Institute of Neurological Disorders and Stroke reveals that patients given t-PA within three hours of suffering an ischemic stroke were 30%-50% more likely to recover than if given no treatment. The success of t-PA, though limited to specific types of stroke and contingent upon prompt administration of the drug, necessitates that medical personnel treat stroke more aggressively than in the past.

Medicinal and Botanical Manufacturing, Medicinals and botanicals, Physicians & Surgeons, Offices of Physicians (except Mental Health Specialists), Plasminogen Activators, Usage, Practice, Drug therapy, Medical personnel, Stroke (Disease), Stroke, Tissue plasminogen activator, Bulk drugs

---

Doctors may boycott to push drug firm to release RU-486

Article Abstract:

Physicians and women's groups are threatening to boycott Hoechst-Roussel Pharmaceuticals if shareholder Roussel Uclaf SA persists in keeping its abortion pill, RU-486, out of the US. Roussel has wavered on marketing the drug here because of the controversy surrounding it. Physicians insist that RU-486 be made available for research since it has the potential to treat breast cancer and other diseases. Hoechst says this is simply a public relations ploy. Company officials claim that they gave up all rights to the drug in 1985.

Pharmaceutical preparations, Drugs, proprietaries, and sundries, Political aspects, Public opinion, Abortifacients, Mifepristone, Hoechst-Roussel Pharmaceuticals Inc.

---

Similar abstracts:

• Abstracts: Service in strict Islamic nation removes alcohol, other drugs from major problem list
• Abstracts: ACGME imposes stiffer standards for subspecialties. Reaction to AMA gift code shows rumblings in the ranks. Surgeons accept work standards for residents
• Abstracts: Evolving strategies for the management of atrial fibrillation: the role of amiodarone. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter
• Abstracts: How essential is an essential drugs policy? Leprosy and guinea-worm disease. Midwives: guardians of the future
• Abstracts: Thrombolytic therapy for elderly patients. Sex, clinical presentation, and outcome in patients with acute coronary syndromes

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.